---
title: CTE 2021 Q&A
description: Establishing Fit-for-Purpose Vendor Oversight for Emerging Biopharma
---

[TriRadial Blog](https://www.triradial.com/blog)

# [CTE 2021 Q&A](https://www.triradial.com/blog/cte-2021-qa)

 Written by [Raphaële Mary](https://www.triradial.com/blog/author/raphaële-mary) | Mar 9, 2022 9:01:14 PM

Raphaële Mary, one of TriRadial's Vendor Outsourcing Management experts, along with Alexandra Kemmer-Brück, Senior Director of Clinical Operations at BioNTech SE, discuss Establishing Fit-for-Purpose Vendor Oversight for Emerging Biopharma during the Clinical Trials Europe conference.

During the Q&A, Raphaële expands on Alexandra's answer to the question, “How do you ensure you get the A Team when you are a small BioPharma?” by outlining several core tenets of TriRadial's approach to Vendor Oversight.

TriRadial focuses on establishing structured frameworks to enable collaborative and scalable relationships.

 

 

 

[View full post](https://www.triradial.com/blog/cte-2021-qa)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Raphaële Mary"
  },
  "dateModified" : "2024-10-29T17:49:45.768Z",
  "datePublished" : "2022-03-09T21:01:14Z",
  "headline" : "CTE 2021 Q&A",
  "image" : {
    "@type" : "ImageObject",
    "height" : 925,
    "url" : "https://www.triradial.com/hubfs/ClinicalTrialsEurope21_Raphael_blogimg.png",
    "width" : 1650
  },
  "mainEntityOfPage" : "https://www.triradial.com/blog/cte-2021-qa",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "TriRadial Blog"
  }
}
```